Assessing driving risk in patients with glaucoma

1. Department of Ophthalmology and Visual Science, Universidade Federal de São Paulo, São Paulo, SP, Brazil
2. Duke Eye Center, Department of Ophthalmology, Duke University, Durham, North Carolina, USA
3. Department of Ophthalmology, Universidade Estadual de Campinas, Campinas, SP, Brazil
4. Department of Ophthalmology and Otorhinolaryngology, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

Carolina P. B. Gracitelli
Department of Ophthalmology and Visual Science
Rua Botucatu, 821
São Paulo, SP - 04023-062 - Brazil
E-mail: [email protected]

Funding: No specific financial support was available for this study.

Disclosure of potential conflicts of interest: Priscila C. Correa, None; Felipe A. Medeiros, F (Financial Support) Alcon Laboratories Inc.; Allergan Inc.; Bausch & Lomb; Carl Zeiss Meditec Inc.; Heidelberg Engineering Inc.; Merck Inc.; National Eye Institute; Sensimed AG; Topcon Inc.; R (Recipient) Alcon Laboratories Inc.; Allergan Inc.; Carl Zeiss Meditec Inc.; Reichert Inc.; C (Consultant) Allergan Inc.; Carl Zeiss Meditec Inc.; Novartis; Ricardo Y. Abe, None; Alberto Diniz-Filho